
Xeris Pharmaceuticals XERS
$ 6.04
-0.82%
Annual report 2025
added 03-02-2026
Xeris Pharmaceuticals P/B Ratio 2011-2026 | XERS
Annual P/B Ratio Xeris Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.7 | -20.5 | -50.5 | 4.02 | 1.98 | 6.94 | 10.8 | 2.38 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 70.7 | -50.5 | 3.22 |
P/B Ratio of other stocks in the Biotechnology industry
| Issuer | P/B Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Applied Genetic Technologies Corporation
AGTC
|
0.382 | - | - | $ 26.5 M | ||
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Allakos
ALLK
|
0.674 | - | - | $ 28.6 M | ||
|
Advaxis
ADXS
|
0.113 | - | -9.65 % | $ 45.9 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 4.55 | -0.66 % | $ 10.9 B | ||
|
Akouos
AKUS
|
0.736 | - | 0.23 % | $ 488 M | ||
|
AlloVir
ALVR
|
-0.258 | - | 4.14 % | $ 49.1 M | ||
|
Compugen Ltd.
CGEN
|
2.26 | $ 2.59 | -5.31 % | $ 242 M | ||
|
I-Mab
IMAB
|
1.12 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
0.485 | $ 0.91 | 3.25 % | $ 6.69 M | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
596 | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
4.36 | $ 22.57 | -0.44 % | $ 3.74 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
Evogene Ltd.
EVGN
|
0.869 | $ 0.78 | -0.66 % | $ 27.9 M | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
Fennec Pharmaceuticals
FENC
|
4.76 | $ 6.33 | -5.52 % | $ 181 M | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
Applied Therapeutics
APLT
|
-31.5 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
0.248 | - | -39.0 % | $ 4.57 M | ||
|
Galapagos NV
GLPG
|
1.67 | $ 27.94 | -1.69 % | $ 2.69 B | ||
|
Genmab A/S
GMAB
|
8.26 | $ 26.19 | -2.24 % | $ 16 B | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
5.67 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.17 | - | 17.91 % | $ 11.1 M | ||
|
Atreca
BCEL
|
0.625 | - | -11.76 % | $ 5.79 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 100.7 | -1.33 % | $ 27.2 B | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | ||
|
Innoviva
INVA
|
0.992 | $ 23.2 | -2.08 % | $ 1.56 B | ||
|
Innate Pharma S.A.
IPHA
|
1.36 | $ 1.45 | 3.57 % | $ 235 M | ||
|
Inventiva S.A.
IVA
|
6.02 | $ 4.93 | -1.5 % | $ 138 M | ||
|
Aquestive Therapeutics
AQST
|
-13.9 | $ 4.06 | -0.73 % | $ 434 M | ||
|
Jaguar Health
JAGX
|
-0.0512 | $ 0.23 | -5.44 % | $ 536 K | ||
|
Arcutis Biotherapeutics
ARQT
|
18.2 | $ 22.63 | -2.86 % | $ 2.88 B | ||
|
KalVista Pharmaceuticals
KALV
|
-308 | $ 26.73 | 38.9 % | $ 1.44 B | ||
|
Autolus Therapeutics plc
AUTL
|
1.81 | $ 1.42 | -4.39 % | $ 378 M | ||
|
Kamada Ltd.
KMDA
|
0.85 | $ 8.14 | -0.09 % | $ 260 M | ||
|
Aptose Biosciences
APTO
|
-0.511 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | - | - | $ 96.9 B | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 2.95 | 1.37 % | $ 4.86 M |